Target-specific recognition
A single-chain variable fragment (scFv)—an engineered antibody fragment—provides the target recognition layer. Changing that recognition element allows the architecture to be adapted for different analytes.
Technology
A molecular switch for faster, more sensitive biosensing.
Leucine Lock is a modular biosensor concept: recognition chemistry finds the target, a controlled molecular interaction activates the system, and an enzyme-linked response amplifies the signal.
Target
Recognition element
Amplified signal
The mechanism
Four engineered layers. One readable answer.
Leucine Lock control
The Leucine Lock motif is designed to control enzyme activity until target binding changes the molecular configuration. That controlled transition links recognition to activation.
Enzymatic amplification
Once activated, the enzyme can produce many detectable output molecules. The deck describes a development target of greater than 10–100× amplification, improving the visibility of low-level biological signals.
Application-specific readout
The amplified result can be coupled to color, luminescence, or electrical detection. This supports simple qualitative tests and instrumented quantitative measurements.
1 / Sensor architecture
A target-gated molecular switch.
The Leucine Lock architecture separates target recognition from signal generation. The target itself acts as a molecular template, positioning two sensor halves at the distance and orientation needed to unlock reporter assembly.
Target recognition
An scFv or alternate binder provides specificity by recognizing the analyte of interest. This modular recognition element can be changed for different targets.
Leucine Lock motif
Complementary leucine zippers are held in a weak cis hairpin state. Target binding brings the two halves into the correct alignment and allows the switch to lock.
Signal generation
A split enzyme or FRET pair activates only when both sensor halves are brought together, converting a specific binding event into a measurable output.
Design logic
No target, no alignment, no assembled reporter. The analyte gates the molecular interaction that produces the signal.
2 / Amplification cycle
One binding event can drive cumulative signal.
Target binding does more than turn the sensor on. It initiates a cycle in which the active reporter can persist after the antigen is released, allowing additional complexes to form and the detectable signal to accumulate.
Capture + align
The antigen holds both sensor halves in close proximity and the correct orientation.
Switch + lock
Weak cis interactions reorient into a stronger trans-bound leucine zipper complex, assembling the reporter.
Release + repeat
The active reporter persists after antigen release. The antigen can participate in additional assembly events, creating cumulative output.
10–100×
Target sensitivity improvement versus comparable non-locking systems, with fluorescence, chemiluminescence, or colorimetric readouts. Performance remains application-specific and subject to assay validation.
Platform design space
Tunable where the assay needs it.
Potential applications
From a 10–15 minute test.
Platform concepts include quantitative insulin detection, viral detection, and respiratory disease panels. Each application requires its own assay development and validation.
Sample
Recognition
Amplification
Answer
Explore an application